AU8407298A - Hexadecasaccharide-protein conjugate vaccine for (shigella dysenteriae) type - Google Patents

Hexadecasaccharide-protein conjugate vaccine for (shigella dysenteriae) type

Info

Publication number
AU8407298A
AU8407298A AU84072/98A AU8407298A AU8407298A AU 8407298 A AU8407298 A AU 8407298A AU 84072/98 A AU84072/98 A AU 84072/98A AU 8407298 A AU8407298 A AU 8407298A AU 8407298 A AU8407298 A AU 8407298A
Authority
AU
Australia
Prior art keywords
hexadecasaccharide
type
protein conjugate
conjugate vaccine
shigella dysenteriae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU84072/98A
Inventor
Vince Pozsgay
John B Robbins
Rachel Schneerson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU8407298A publication Critical patent/AU8407298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU84072/98A 1997-07-17 1998-07-15 Hexadecasaccharide-protein conjugate vaccine for (shigella dysenteriae) type Abandoned AU8407298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5286997P 1997-07-17 1997-07-17
US60052869 1997-07-17
PCT/US1998/014698 WO1999003871A1 (en) 1997-07-17 1998-07-15 Hexadecasaccharide-protein conjugate vaccine for shigella dysenteriae type 1

Publications (1)

Publication Number Publication Date
AU8407298A true AU8407298A (en) 1999-02-10

Family

ID=21980431

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84072/98A Abandoned AU8407298A (en) 1997-07-17 1998-07-15 Hexadecasaccharide-protein conjugate vaccine for (shigella dysenteriae) type

Country Status (3)

Country Link
EP (1) EP1000076A1 (en)
AU (1) AU8407298A (en)
WO (1) WO1999003871A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102366630B (en) * 2003-03-07 2015-04-01 惠氏控股公司 Polysaccharide-staphylococcal surface adhesion carrier protein conjugates for immunization against nosocomial infections
CA2434668A1 (en) 2003-07-04 2005-01-04 Laurence Mulard Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a
US8747863B2 (en) 2008-08-15 2014-06-10 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Vaccine for shigella
CN102257000B (en) 2008-10-21 2014-10-08 国际疫苗研究所 Novel shigella frotein antigens and methods
CA2766629C (en) 2009-06-22 2020-03-24 Wyeth Llc Immunogenic compositions of staphylococcus aureus antigens
BRPI1011753B8 (en) 2009-06-22 2021-05-25 Wyeth Llc immunogenic conjugates of capsular polysaccharide from staphylococcus aureus serotypes 5 and 8, their use and compositions comprising them

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79346A0 (en) * 1986-07-06 1986-10-31 Yeda Res & Dev Shiga vaccine

Also Published As

Publication number Publication date
WO1999003871A1 (en) 1999-01-28
EP1000076A1 (en) 2000-05-17

Similar Documents

Publication Publication Date Title
AU6565396A (en) Surgical clamping mechanism
AU9036098A (en) Parallel mechanism
AU3680897A (en) Surgical clamping mechanism
AU1617399A (en) Glp-1 formulations
AU1383099A (en) Microelectromechanical positioning apparatus
AU1441797A (en) (2-dimethylphenoxy-1-methylethyl) ethylamine
AU7677898A (en) Lithography system
AU6198498A (en) Prosthesis
AU5773198A (en) Can ends
AU2523895A (en) Protein-scum remover
AU3253695A (en) Coprinaceae laccases
AU6107698A (en) Release mechanism
EP0790218A3 (en) Transfer mechanism
AU7068598A (en) Clamps
AU1420897A (en) Conjugate vaccine for (salmonella paratyphi) a
AUPO863197A0 (en) Novel derivatives
AU8407298A (en) Hexadecasaccharide-protein conjugate vaccine for (shigella dysenteriae) type
AU4392097A (en) A transfer aid
AU9548698A (en) Incinerator apparatus
AU8232498A (en) Gripping aid
AU2428697A (en) Offset transfer case
AU5814498A (en) Novel release latch - c-i-p
AU6736998A (en) Fiv vaccine
AU685728B1 (en) Auto-focus mechanism
AU1041597A (en) Remedy for tragomaschalia containing adrenocorticosteriodal preparation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase